Stocktoria
BIOVIE INC. BIVI
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2014-01-14
BIOVIE INC. statistics & valuation
Market cap$14.6M
P / B0.8×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Return on assets | -81.4% | -127.4% | -143.2% | -129.7% | -2154.1% |
| Return on equity | -92.3% | -207.1% | -327.6% | -710.6% | -2579.0% |
| Current ratio | 9.10 | 2.57 | 2.35 | 4.50 | 4.62 |
Source: SEC EDGAR filings · CIK 0001580149 · as of 2025-06-30. Facts from filings plus Stocktoria's own computed scores — not investment advice.